Website Header with Language Selector and Dropdowns
Image

Ecamsule USP Related Compound G


Catalog Number: CL-ECME-08
CAS No.: NA
Mol.F: C18H19O5S : Na
Mol.W: 347.4 : 23.0
Inv. Status: Custom Synthesis

Chemical Name: 4-((E)-((1SR,4SR)-7,7-Dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt.

Country of Origin: India

Product Category: Ecamsule Impurities


Ecamsule USP Related Compound G is identified by CAS No. NA and is chemically known as 4-((E)-((1SR,4SR)-7,7-Dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt.

Ecamsule USP Related Compound G is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Ecamsule.

Page Keywords: Buy Ecamsule USP Related Compound G | Purchase Ecamsule USP Related Compound G | Ecamsule USP Related Compound G suppliers | Ecamsule USP Related Compound G manufacturers | Ecamsule USP Related Compound G price | Ecamsule USP Related Compound G Importer | Ecamsule USP Related Compound G Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-ECME-01
CAS No: 92761-26-7
Mol Wt: 562.7
Mol F: C28H34O8S2
Inv. Status: Custom Synthesis
CAT No: CL-ECME-04
CAS No: 589-29-7
Mol Wt: 138.2
Mol F: C8H10O2
Inv. Status: Custom Synthesis
CAT No: CL-ECME-02
CAS No: 3006-96-0
Mol Wt: 152.1
Mol F: C8H8O3
Inv. Status: Custom Synthesis
CAT No: CL-ECME-05
CAS No: 100-21-0
Mol Wt: 166.1
Mol F: C8H6O4
Inv. Status: Custom Synthesis
CAT No: CL-ECME-03
CAS No: [5872-08-2]
Mol Wt: 232.3
Mol F: C10H16O4S
Inv. Status: Custom Synthesis
CAT No: CL-ECME-06
CAS No: NA
Mol Wt: 349.4 : 23.0
Mol F: C18H21O5S : Na
Inv. Status: Custom Synthesis
CAT No: CL-ECME-07
CAS No: NA
Mol Wt: 364.4
Mol F: C18H20O6S
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.